Synaptogenix Inc (SNPX)

[InTheTrenches]

Rarely is actual interim data released by a company. Some trials have a Data Safety Monitoring Board review interim results (at a predetermined time) for futility and safety issues, both of which are reasons that a trial can be halted. But it's extremely rare to see a trial halted because the drug arm is so much better than the placebo arm.

I don't anticipate a DSMB interim review of our data for the upcoming trial. I don't think we had an interim look during the last trial, and the safety is pretty well established.

---------------------------

Cyosol: thanks for the extract of info from the 10k report.